Can butyrate prevent colon cancer? The AusFAP study: A randomised, crossover clinical trial

Can butyrate prevent colon cancer? The AusFAP study: A randomised, crossover clinical trial

Increased colonic butyrate from microbial fermentation of fibre may protect from colorectal cancer (CRC). Dietary butyrylated high amylose maize starch (HAMSB) delivers butyrate to the large bowel. The objective of this clinical trial (AusFAP) is to evaluate potential chemoprotective effects of HAMS...

Full description

Bibliographic Details
Main Authors: Julie Clarke, Alex Boussioutas, Brooke Flanders, Trevor Lockett, Karen Harrap, Ian Saunders, Patrick Lynch, Mark Appleyard, Allan Spigelman, Don Cameron, Finlay Macrae
Format: Article
Language:English
Published: Elsevier 2023-04-01
Series:Contemporary Clinical Trials Communications
Subjects:
Colorectal cancer (CRC)
Butyrate
Familial adenomatous polyposis (FAP)
Short chain fatty acids (SCFA)
Online Access:http://www.sciencedirect.com/science/article/pii/S2451865423000388

Internet

http://www.sciencedirect.com/science/article/pii/S2451865423000388

Similar Items